MetaVia MTVA
NASDAQ MTVA
$1.35 +0.01 (+0.75%)
As of: Oct 22, 2026 · 9:30 AM EDT

MetaVia (MTVA) EPS (Diluted) (2020 - 2026)

Updated

MetaVia (MTVA) reported EPS (Diluted) of -$0.90 for Q2 2026, compared with -$2.87 a year earlier.

Analysis

MetaVia (MTVA) EPS (Diluted) (2020 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, MetaVia's EPS (Diluted) came in at -$2.47; for FY2025, it came in at -$7.36.

  • By year, EPS (Diluted) came in at -$39.13 in FY2024, -$27.05 in FY2023, -$477.57 in FY2022 and -$1,744 in FY2021.
  • The Q2 2026 figure ranks as the highest quarterly EPS (Diluted) in data going back to Q3 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Eli Lilly 1,163.48 Bn 1,132.06 Bn 19.71 Bn 7.94
2 Johnson & Johnson 631.16 Bn 549.69 Bn 17.26 Bn 2.27
3 AbbVie 502.63 Bn 475.74 Bn 12.70 Bn 2.04
4 Merck 378.53 Bn 332.91 Bn 12.21 Bn -0.54
5 Novartis Ag 302.83 Bn 266.82 Bn 11.24 Bn 1.67
6 Astrazeneca 265.92 Bn 239.60 Bn 12.86 Bn 1.60
7 Amgen 240.87 Bn 196.27 Bn 7.24 Bn 4.37
8 Gilead Sciences 194.04 Bn 168.24 Bn 6.22 Bn -8.44
9 Pfizer 172.14 Bn 118.78 Bn 10.94 Bn -0.04
10 MetaVia 8.01 Mn -46.80 Mn - -0.90
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.90
Dec 31, 2025 -1.11
Sep 30, 2025 -1.52
Jun 30, 2025 -2.87
Mar 31, 2025 -3.93
Dec 31, 2024 -7.34
Sep 30, 2024 -6.09
Jun 30, 2024 -20.37
Mar 31, 2024 -14.51
Dec 31, 2023 -11.53
Sep 30, 2023 -8.27
Jun 30, 2023 -1.60
Mar 31, 2023 -5.66
Dec 31, 2022 -159.58
Sep 30, 2022 -308.25
Jun 30, 2022 -327.09
Mar 31, 2022 -284.71
Dec 31, 2021 -522.25
Sep 30, 2021 -414.64
Jun 30, 2021 -470.54
API Access

MetaVia EPS (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-diluted&ticker=MTVA&period=max&api_key=YOUR_API_KEY